chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Right eye lid of patient had swelling; Eye redness in both eyes; A 12 year old received the vaccine/1st dose administered to a 12 year old patient; This spontaneous case was reported by an other health care professional and describes the occurrence of SWELLING OF EYELID (Right eye lid of patient had swelling), OCULAR HYPERAEMIA (Eye redness in both eyes) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 12 year old received the vaccine/1st dose administered to a 12 year old patient) in a 12-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Aug-2021, the patient experienced SWELLING OF EYELID (Right eye lid of patient had swelling), OCULAR HYPERAEMIA (Eye redness in both eyes) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 12 year old received the vaccine/1st dose administered to a 12 year old patient). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (intramuscular) for Adverse event, at a dose of 50 milligram. On 04-Aug-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 12 year old received the vaccine/1st dose administered to a 12 year old patient) had resolved. At the time of the report, SWELLING OF EYELID (Right eye lid of patient had swelling) and OCULAR HYPERAEMIA (Eye redness in both eyes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided  Treatment medication was not provided  After vaccination  the patient was fine but  within 15 minutes of the vaccine had a delayed reaction where it was noticed that the  right eyelid of the patient had swelling and had eye redness in both eyes and came back to the clinic and was administered 50mg of Benadryl intramuscularly.
Increased joint pain after getting Second Covid booster; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Increased joint pain after getting Second Covid booster) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On an unknown date, the patient experienced ARTHRALGIA (Increased joint pain after getting Second Covid booster). At the time of the report, ARTHRALGIA (Increased joint pain after getting Second Covid booster) had resolved.            No concomitant medication were reported.  No treatment drug were reported. Causality for RINVOQ drug was reported as no reasonable possibility.
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unspecified age and gender. The patients medical and concurrent conditions were not reported. On an unspecified date, the unspecified number of patients were administered improperly stored doses of GARDASIL (lot K007828, expiry date: 02-MAR-2017; lot K009482, expiry date: 06-MAR-2017; lot K011562, expiry date: 08-AUG-2017). No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
c/o fever 103.5R @ 530PM 5FEB91 & was 105R @ 2PM 6FEB91; Very irritable for 24 hrs - 36 hrs p/receiving vaccines.
Pt developed urticaria and complained of tingling at lips and upper airway.  Pt assessed; pt airway patent, breathing normal and non-labored, lungs clear- upper and lower lobes bilaterally. Pt administed 50 mg at 6:11 PM IM Diphenhydramine and then 25mg at 6:19 Diphenhydramine upon worsening urticaria.  Emergency Services contacted for transport to hospital.
Patient received ZOSTAVAX vaccine 5/13/08 afterwards after injection, patient noted a 2" circular raised area at the injection site. It was somewhat hard and slightly itchy. Patient called me 5/16 to report this to me and said she has seen no improvement.
stroke symptoms; lethargy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2 NOS), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown", described as "stroke symptoms"; LETHARGY (non-serious), outcome "unknown". Clinical course: Patient had been experiencing side effects including but not limited to stroke symptoms and lethargy since patient received the first COVID vaccine.   The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Vaccine given on Friday. Monday I woke up from numbness and tingling in my left arm. As the day progressed numbness and tingling progressed to my left leg. Tuesday night I began to have a head ache in the left side of my head with neck pain. I also had maybe 4-5 dizzy spells on Tuesday. Numbness, tingling, headach, and dizzy spells continued into Wednesday when I went to the local urgent care. Blood work was done and everything showed to be in normal limits. CAT scan was done and came back negative. Neurological exam also came back normal.
Information has been received from a nurse concerning a 16 month old male pt who on 10/30/2000 was vaccinated with a dose of MMR live vaccine. Concomitant therapy on 10/30/2000 included a dose of pneumococcal 4 6N 9v 14 18C 19F 23F conjugate vaccine (crm197 protein) (Prevnar). Subsequently 9 days after vaccination, on 11/08/2000 the pt developed a  fever of 104.4. Subsequently, the pt recovered from fever of 104.4 on an unknown date. Additional information has been requested.
Palms became sweaty Narrative:  Noted palms becoming sweaty after 30 minutes of having the vaccine. Initial blood pressure 86/55 P 84 (lying down) with 97 O2 Sat. Denied difficulty breathing. Interval blood pressure 97/57 p. 83 regular. Final blood pressure 137/74 (sitting) P. 90. Left in stable condition to continue being a part of the COVID vaccination team as check-out.
On day 4 following dose 2 of Moderna series, pt developed fever, chills, fatigue, malaise and self-medicated with ibuprofen and acetaminophen. After a "few" days of feeling unwell despite treatment, presented to ER and was found to have AKI, hyponatremia, and thrombocytopenia. Over the course of several days rapidly deteriorated and developed MSOF, including liver failure, DIC, respiratory failure requiring intubation, and shock requiring pressors. Workup for VTE, including V/Q scan, LE dopplers, and head CT negative for thrombosis. Ferritin was found to be highly elevated (12,000) suggestive of hemophagocytic lymphohistiocytosis (HLH). Per ER report, marrow positive for hemophagocytosis on smear. At time of report, transferred to Cancer Center for HLH treatment, currently in ICU, intubated, sedated, and on pressors. PF4 antibody pending.
noticed inc hair/loss/breakage probably since before JUN93; last hair perm in JUN93: tints hair;
Pt. developed rah on (L) thigh sl. redness, small bumps all over thigh
ANIXETY, FEVER, CHILLS, TROUBLE BREATHING, POSSIBLE SWELLING IN MOUTH/TONGUE ALL OCCURED VERY QUICKLY AFTER VACCINE.
I developed a hive on my chin; Felt like left side of tongue was a bit swollen; Face numbness sensations; This case was reported by a consumer via interactive digital media and described the occurrence of hives in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st June 2022, the patient received the 1st dose of Shingrix. On 2nd June 2022, 1 days after receiving Shingrix, the patient experienced hives, swollen tongue and numbness facial. On an unknown date, the outcome of the hives, swollen tongue and numbness facial were unknown.   It was unknown if the reporter considered the hives, swollen tongue and numbness facial to be related to Shingrix.     Additional Information: GSK Receipt Date: 6-JUN-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received dose of Shingrix vaccine and experienced a hive on his/her chin and then also felt like left side of tongue was a bit swollen and some face numbness sensations. The patient would like to talk to someone to determine if it was safe for him/her to get 2nd dose. Additional supportive information: The follow-up would not possible as no contact details were available.
THE PATIENT'S MOTHER INDICATES PRESENTS WITH PAIN IN THE BODY, AND WAS TAKEN TO THE HOSPITAL WHERE HE WAS FOR 2 DAYS, AND THEY DIAGNOSED SKELETAL MUSCLE DAMAGE
(R) upper arm with redness/swelling (mid to lower lateral portion to (R) arm) redness is about 6 inches long, 3 inch (approx) wide, (R) arm 25cm - circumference.
Patient experienced some soreness in arm after vaccination. Woke up early the next morning after vaccination and injection site was red, swollen and warm to touch (~1 inch diameter). No other symptoms- no itching, no shortness of breath, only localized reaction. Since she noticed it, it had not gotten any worse. Recommended for patient to take some Benadryl and follow up with physician if the Benadryl did not help it.
Patient received vaccine at 12:01, she stated that approximately 12:30  she noticed her right palm felt itchy and she noticed red bumps on the inside of her right wrist.   She reported the symptoms to the onsite paramedics.  She stated that she was placed on a stretcher and given 60 mg of liquid benadryl by the paramedics.   She stated she started feeling dizzy, but after 3 minutes the dizziness resolved.  She stated that soon after that the itchy right palm resolved, and the red spots on her right wrist diminished.  She stated the paramedics took her blood pressure, 150/100 and placed her on oxygen.  She stated she was monitored until 1:30 pm, then was discharged, at the time of discharge she had no dizziness, no itching, and only slight red bumps on her wrist.  When she got home she stated her eyes felt itchy at about 5:30 pm,  she took 2 OTC benadryl tablets, the symptoms resolved.  She has been asymptomatic since that time.
Guest completed post observation period and was check out when they became lightheaded and requested a chair to sit in.  Guest reports lightheadedness is common for them as they are a cancer patient. Guest declined aid response and was moved in wheelchair to their personal vehicle to go home with their husband.  No interventions beyond providing wheelchair. Guest reported improvement when sitting.
Trigeminal neuralgia; Bell's Palsy; pain in the ear; Fatigue; Headache; A spontaneous report was received from a consumer concerning 74-years-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced trigeminal neuralgia, Bell's palsy, fatigue, headache, and pain in the ear.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 12 Feb 2021, 2 days prior to the onsent of the events of fatigue and headache, the patient received their first of two planned doses of mRNA-1273(lot/batch number: 007M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 13 Feb 2021, the patient experienced fatigue and headache.  On 14 Feb 2021, she had swelling in her left jaw. She described it as if there was "an abscess tooth and my side of the face swelled up as if I had the mumps." She had facial pain and her lips were tingling and numb. Her dentist determined that she had no infection, no tooth abscess, or jaw issue to cause this extreme swelling. On an unknown date in Feb 2021, Her physician ran some tests and diagnosed her with bells palsy and trigeminal neuralgia based on examination.  On an unknown date in Feb 2021, CRP (C-reactive protein) was 135.2 (0-5).  From 19 Feb 2021 to 21 Feb 2021, the patient was treated with prednisone 20 mg. The patient's swelling went down and was able to open her mouth again.  On 22 Feb 2021, her pain was back and she experienced severe pain in the ear to the point where it woke her up at 3:30 am and she couldn't wear her glasses either. She was taking pain medication hydrocodone 10.325 mg to help with the pain. As of 22Feb2021, her pain and swelling was back.  Treatment for the pain included hydrocodone 10.325 mg.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events trigeminal neuralgia, Bell's palsy, fatigue, headache, and pain in the ear were not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
pain in her arm where she received the injection; The pain extends from her arm up into her neck; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th March 2020, the patient received Shingrix (intramuscular) .5 ml. On 21st March 2020, 1 days after receiving Shingrix, the patient experienced pain in arm and neck pain. On an unknown date, the outcome of the pain in arm was not recovered/not resolved and the outcome of the neck pain was unknown.   It was unknown if the reporter considered the pain in arm and neck pain to be related to Shingrix.  Additional details were provided as follows: The patient started that she experienced pain in her arm where she received the injection the next. The pain continued to get worse and is still very painful. The pain extends from her arm up into her neck.
patient's arm is still hard; swollen; sore; constant headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (patient's arm is still hard), VACCINATION SITE SWELLING (swollen), VACCINATION SITE PAIN (sore) and HEADACHE (constant headache) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for Headache.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INDURATION (patient's arm is still hard), VACCINATION SITE SWELLING (swollen), VACCINATION SITE PAIN (sore) and HEADACHE (constant headache). At the time of the report, VACCINATION SITE INDURATION (patient's arm is still hard), VACCINATION SITE SWELLING (swollen), VACCINATION SITE PAIN (sore) and HEADACHE (constant headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Patients wife reported, her husband takes acetaminophen (paracetamol) for constant headache, he always takes it a lot.    Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: reporter declined Follow-up said "her husband is fine now; it was a while ago and I don't share email address.
Nausea, emesis, headach, exacerbation of chronic low back pain. The patient explains that she has been experiencing the nausea since her COVID-19 vaccination
Vaccines were given on 3/10/03. Pt presented to clinic on 3/12/03 with Ld red, warm to touch with induration. Rx'd Keflex 250mg po qid z 7d. Dx cellulitis. Pt to return to clinic week of March 17-21.
Throat closed up when I woke up the next morning. Same symptoms as previous angioedema episodes.
12/30 9:30 am developed angioedema.  Swelling of face, lips, tight throat.  Also had bright red rash over body trunk and arms.  Both palms were red, hot and painful.
Injection site swelling. Muscle soreness in left arm, severe enough to take ibuprofen. Back ache/whole body ache, severe enough to take more ibuprofen (800mg, twice a day). Headache, dizziness and blurred vision.
42 yo female [ME] nurse epidemiologist revaccinee DOV 05/22/03 complained of headache on Post vaccination day 6.  Headache global, no fever, no vomiting, no confusion, no ataxia.  Took Tylenol, motrin, Darvocet with minimal relief.  To see neurologist tomorrow.  Pt. has history of headaches, typically tension-like occipital that are usually relieved with meds above.  Pt. also has two vesicles on upper philtrum that appeared abruptly.  Specimens will be collected for HSV and Vaccinia.  Pictures are pending.  Pt. has history of cold sores.  Working diagnosis, neurologic other than encephalitis, in this case headache.
vaccine was reconstituted with sterile water instead of normal saline and administered.   Patient has not reported any adverse effects at this time.
LIGHT HEADED; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 12-MAR-2021, the patient experienced light headed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of light headed was not reported. This report was non-serious.
Redness, swelling, tenderness, warmth to touch at site of injection lasting several days.
Information has been received on 15-FEB-2019 from a lawyer regarding a case in litigation concerning a 69 year old male patient. The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient was prescribed the ZOSTAVAX vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 02-JUL-2015 the patient was administered the ZOSTAVAX vaccine by a healthcare provider. On or about 31-MAY-2017, the patient was treated by a physician for shingles as a result of vaccination with ZOSTAVAX. Additional information has been requested.
Pt presented ~46 hours post PNEUMOVAX 23 c/o severe pain, redness & swelling L deltoid.
Patient received the Moderna Vaccine  1/2/21 at his VA Clinic. He received the vaccine that morning and by the evening he was not feeling well. He developed cough, weakness and fever and now is unable to ambulate. He has since been hospitalized and has tested positive for COVID-19.
2 days following vax pt began having hives on back & neck; hives have cont to present time (22 days);
This case was reported by a nurse and described the occurrence of inappropriate schedule of vaccine administered in a 37-year-old female patient who received Hepatitis B vaccine. Co-suspect products included TWINRIX. Previously administered products included TWINRIX (dose 1 in 2002). In June 2014, the patient received Hepatitis B vaccine. On 28th October 2014, the patient received the 2nd dose of TWINRIX. On an unknown date, an unknown time after receiving Hepatitis B vaccine and TWINRIX, the patient experienced inappropriate schedule of vaccine administered and wrong vaccine administered. On an unknown date, the outcome of the inappropriate schedule of vaccine administered and wrong vaccine administered were unknown. Additional information received: TWINRIX given to adult patient in 2002, then Hep B vaccine given to same patient 6/2014, and a final TWINRIX on 10/28/2014. No lot numbers or exp date currently available.
pt started crying high pitched scream from 3PM-7PM unconsolable; temp 103 APAP relieved; sore, swollen leg; took only a sm amt of formula & vomited it up; cranky;
Information has been received from a 37 year old female registered nurse who on 11/28/99 was vaccinated with a third dose of Hep B IM. Twelve hours post vax, the pt experienced painful soreness in arm, red swollen and warm to touch as well as joint pain in the same arm of vaccine. Also experienced an extreme drop in antibody levels from January to August. Follow-up information from the registered nurse reported that approximately 4 days post onset, she recovered.
Patient presented for second dose of Hepatitis B vaccine. Pharmacist administered the vaccine. Patient came back a month later to inform that her arm is sore, warm, and a bit swollen. She says it feels like a lump is in there.
found pulseless, not breathing in bed, resuscitation without success. COD -- SIDS as per autopsy report.
shivering 2 hours then stopped, tiredness, muscle pain, headache,  nausea all subsided after about 24 hours
First dose of Shingrix on 30/Oct/2019 and has not received dose two; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 30th October 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: Age at vaccination was not applicable for this report.  A pharmacist reported that a patient received the first dose of Shingrix and had not received dose two which led to incomplete course of vaccination. The reporter consented to follow up.
On 9OCT2003 at 12:00 the vaccinee developed large erythema at the injection site after receiving Fluvirin in her left deltoid muscle on 8OCT2003. The vaccinee had not recovered at  the time of the report. There was insufficient information to determine the reporter's causality assessment. Further information received from a health care professional on 10NOV2003 indicated that the vaccinee received Fluvirin on 9OCT2003. The erythema at the injection site began on 10OCT2003 and resolved 3 days later. The vaccine is pregnant and in her first trimester. Follow up pending. Cross reference with: PJP200300791, PJP200300793, PJP200301113. Follow up received 29JUNE2004. Vaccinee had a positive pregnancy test on 9OCT2003 (day of vaccination). The vaccines gave birth to a normal healthy baby girl on 2JUNE2004; the baby was delivered by repeat Caesarean Section with no complications. Concomitant medications during pregnancy included, prenatal vitamins, nitrofurantoin for urinary tract infection and amoxicillin for bronchitis.